At Nashik Diagnopein Centre, this test is performed using high-precision molecular technology that delivers sensitive, accurate, and clinically reliable results. D
JAK-2 Mutation Detection is an essential molecular diagnostic test used to identify mutations in the Janus Kinase 2 (JAK2) gene, which play a major role in abnormal blood cell production. The most common mutation tested is JAK2 V617F, strongly associated with Myeloproliferative Neoplasms (MPNs) such as Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF).
The presence of a JAK2 mutation is a hallmark indicator of disorders such as:
Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Chronic Myeloproliferative Neoplasms
Identifying the mutation provides direct evidence of abnormal bone marrow cell behavior, helping differentiate between various blood disorders.
JAK-2 test results play a crucial role in:
Selecting targeted therapies
Determining disease severity
Choosing long-term management strategies
Assessing the risk of clot formation
Patients with a positive JAK2 V617F mutation have different treatment responses compared to non-mutated cases.
Early diagnosis through JAK-2 Mutation Detection helps prevent:
Stroke
Heart attack
Deep vein thrombosis
Pulmonary embolism
Progressive bone marrow fibrosis
Organ enlargement (spleen/liver)
Monitoring JAK-2 mutations allows clinicians to track disease progression and modify treatment promptly.
Differentiates Overlapping Conditions
Symptoms of MPNs overlap with anemia, infections, inflammatory disorders, and vitamin deficiencies.
JAK-2 Mutation Detection provides clarity and eliminates diagnostic uncertainty.
At Nashik Diagnopein Centre, the test is handled by trained molecular pathology professionals to ensure the highest standards of diagnostic accuracy.
Peripheral blood sample (EDTA vial)
Bone marrow sample (if clinically recommended)
The centre uses advanced molecular techniques, such as:
PCR (Polymerase Chain Reaction)
Real-Time Quantitative PCR
High-Sensitivity Allele-Specific Assays
These methods detect even low-level mutation variants, ensuring a detailed molecular profile.
Sample collection: Blood sample collected under aseptic conditions.
DNA extraction: Genetic material isolated from blood cells.
PCR amplification: Targeted amplification of JAK2 gene region.
Mutation analysis: Assessment for JAK2 V617F or Exon 12 mutations.
Interpretation: Mutation presence, mutation load, and clinical significance evaluated.
Reporting: A detailed molecular report is generated with clinical correlation.
Results typically available within 24–48 hours.
The test is recommended for individuals with:
Elevated hemoglobin or hematocrit
Increased platelet count
Enlarged spleen
Unexplained clotting or bleeding
Suspicion of MPNs
Early testing at Nashik Diagnopein Centre ensures timely clinical decisions.
The JAK-2 test includes evaluation of key genetic markers that help determine the nature and severity of the condition.
JAK-2 V617F Mutation
JAK-2 Exon 12 Mutation
What These Parameters Indicate
Presence of mutation: Confirms underlying MPN.
Type of mutation: Helps distinguish PV from other MPNs.
Mutation load: Assists in predicting disease severity and therapy response.
The molecular insights obtained from these parameters offer a comprehensive picture of bone marrow health and disease progression.
Highly sensitive and advanced molecular testing
Accurate and fast results
Expert clinical interpretation
Suitable for early diagnosis and long-term monitoring
Helps prevent serious clot-related complications
Trusted diagnostic support for hematologists
Patient-friendly sample collection and seamless reporting
Choosing the right diagnostic partner is crucial when it comes to molecular and genetic testing. Diagnopein Nashik Centre ensures high-quality, accurate, and patient-focused diagnostic services designed to support timely medical decisions. Here’s why patients and clinicians trust Diagnopein for advanced tests like JAK-2 Mutation Detection:
1. Advanced Molecular Diagnostic Technology
Diagnopein uses state-of-the-art molecular platforms, including high-sensitivity PCR and DNA amplification systems. These technologies ensure accurate detection of even low-level JAK-2 mutations, providing clarity in cases where early diagnosis is critical.
2. Expert Pathologist & Skilled Laboratory Team
The test is handled by experienced molecular pathologists and trained lab technologists who specialize in genetic and hematological testing. Their expertise ensures precise interpretation and clinically meaningful results.
3. Fast & Reliable Turnaround Time
Diagnopein understands the urgency of diagnosing conditions like Polycythemia Vera, Essential Thrombocythemia, and Myelofibrosis. With streamlined processes, most JAK-2 test reports are delivered within 24–48 hours, helping doctors initiate timely treatment.
4. High Accuracy & Quality Assurance
The centre follows strict quality control and validation protocols, ensuring accurate, reproducible, and trustworthy results. Every test undergoes multiple checks to ensure diagnostic excellence.
5. Comprehensive Testing Support
Beyond the JAK-2 test, Diagnopein provides a wide range of:
Hematology tests
Molecular diagnostics
Genetic panels
Oncology markers
This allows clinicians to correlate JAK-2 results with other necessary investigations seamlessly.
6. Patient-Friendly Sample Collection
Diagnopein offers smooth and comfortable sample collection services with:
Minimal waiting time
Hygienic environment
Trained phlebotomists
Home sample collection (if applicable)
This ensures convenience for patients who require frequent follow-ups.
7. Trusted by Physicians Across Nashik
Clinicians rely on Diagnopein for accurate molecular results that directly guide treatment decisions. The centre’s reputation is built on precision, consistency, and ethical diagnostic practices.
8. Transparent and Affordable Pricing
Diagnopein provides high-quality molecular tests at cost-effective rates, making advanced diagnostics accessible to everyone without compromising accuracy or technology
This test is crucial for diagnosing MPNs, providing prognostic information, monitoring disease progression, and guiding treatment decisions based on the specific JAK2 mutation identified.
Yes, the test can be repeated if necessary, especially if there is a change in symptoms or if monitoring of disease progression is required.
Generally, no special preparation is required for the JAK2 mutation detection test. However, it is always best to follow any specific instructions given by your healthcare provider.
A negative JAK2 test result suggests that no JAK2 mutations were detected. However, it does not rule out the possibility of an MPN, as other mutations or conditions may be responsible for the symptoms.